Deal Pipeline

Reference Summary Focus Country Raising Stage
1 A Biomed company aiming to leverage proprietary computational systems including AI to accelerate development of novel drug alternatives to life threatening diseases like cancer, bacterial infections and muscular dystrophy. AI & Drug Development USA $20m IND
2 A Biomed company providing specialised rehabilitation services to treat patients suffering from drug addiction and opioid dependence with clinics using therapies from a specialised drug. The company is focused on creating a diverse real estate portfolio with healthcare and detox related assets whose sole purpose are to establish turn-key addiction recovery facilities. Addiction Canada $5m Pre revenue
3 A Biomed company that is developing a novel therapeutic class of medicines that use the body's natural immune response to decrease inflammation and stimulate repair mechanisms, thereby repairing the damage caused by disease and slowing aging. Aging USA $50m Phase 3